MedPath

Evaluation of sedative effect of ketamine/fentanyl and midazolam/fentanyl on dental uncooperative childre

Phase 3
Conditions
ncooperative Pediatric Dental patient.
Generalized anxiety disorder
F41.1
Registration Number
IRCT20140106016106N7
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Children aged 2 to 6 years
Patients needing at least 2 similar dental treatment sessions
?treating each tooth requires local Anesthesia.
pediatric patients in ASA I
Uncooperative child definitely negative (in Frankl scale)

Exclusion Criteria

Patients with any Systemic disease
Patients having common cold at treating session
any contraindication for the use of drugs
any contraindication for the use of sedation
Drug Allergy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Induced sufficient sedation for delivering dental treatment. Timepoint: baseline, at IV sedation, every 15 min afterwards, at discharge. Method of measurement: Recording data in prepared forms in addition to a questionnaire.
Secondary Outcome Measures
NameTimeMethod
Adverse effects of the sedative drugs used. Timepoint: at discharge and 24 hours later. Method of measurement: Questionnaire and by phone.
© Copyright 2025. All Rights Reserved by MedPath